199
A South Africa-focused DNA testing kit that uses saliva samples and polygenic risk scoring to deliver non-diagnostic insights on health traits, pharmacogenomics, and ancestry.

BioCertica is a direct-to-consumer DNA testing platform and Africa's first digital biobank, combining advanced genetic testing with encryption technology to deliver personalised health, lifestyle, and ancestry insights. Users order an at-home saliva kit with prepaid return shipping, and within 6β8 weeks receive results via a secure mobile app. The platform analyses 800,000 genetic markers, enhanced through Polygenic Risk Scoring (PRS) to cover up to 2 million biomarkers β making it the first African company to introduce PRS to consumer DNA testing. Report categories include nutrition & wellbeing, fitness & weight management, skin care, cardiovascular health, mental health, autoimmune & metabolic health, pharmacogenomics, COVID-19 response, and ancestry (not genealogy). Additional reports can be unlocked in-app post-purchase, and results can be shared with practitioners via a dedicated portal. Lab processing is conducted in-house at the University of Stellenbosch. All results are non-diagnostic.
As of May 11, 2026, Biocertica is rated 5.0 on the App Store from 1 review and 3.1 on Google Play from 39 reviews with 1K+ installs.
DD Dave found 2 key people at Biocertica, including 1 Founder, and 1 VP spread across 2 countries. See how we get product data
DD Dave found 1 articles about Biocertica. See how we get product data
No reviews yet. Be the first to review this product.
DD Dave found that Biocertica has raised $2.3M across 3 rounds, backed by 1 investor. Their latest round was a Other in Sep 2023. See how we get product data